November 24, 2025 · Form 4 insider transaction
Mowad-Nassar Nicole bought 1,331 shares of ResMed Inc. at $250.52 per share, a transaction worth $333.4K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Represents the date on which options first become exercisable. The options vest on the earlier of (i) November 11, 2026, or (ii) the date of the first annual meeting of stockholders of the Company following the Grant Date.